News

Our Chief Commercial Officer, David McClelland, recently sat down with BioPharma Boardroom to discuss how Symbiosis is strategically scaling to...

CPHI Online, the global community for the pharmaceutical industry, recently spoke with Symbiosis Chief Commercial Officer Joanne Anderson, to get...

Symbiosis has expanded its Quality Control (QC) laboratory with the installation of a new 30°C stability chamber. This addition enables...

Symbiosis is delighted to announce the appointment of Joanne Anderson as our Chief Commercial Officer (CCO). With over 25 years...

International Day of Woman and Girls in Science is an initiative launched by the United Nations in 2015 to recognise...

Symbiosis has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK. The project, delivered for...

Symbiosis is delighted to have been formally presented with a 2025 King’s Award for Enterprise in the International Trade category,...

Symbiosis has successfully completed qualification of its new FPD 50 Flexicon automated fill/finish line at its new commercial production facility...

We’re delighted to announce the appointment of Wendy Cook as a Qualified Person (QP) to further strengthen our regulatory and...

We’re delighted to announce the successful completion of our 1,000th sterile drug product batch, marking a significant milestone in our...

We’re extremely proud to announce that Symbiosis has been awarded a 2025 King’s Award for Enterprise in the International Trade...

Symbiosis is delighted to announce the successful completion of the latest audit by the UK’s Medicines and Healthcare products Regulatory...